Stock & Company Details
Caribou Biosciences Inc $CRBU
Price:
N/A
N/A
107M
$52M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.34
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CRBU technical indicators
Latest Caribou Biosciences Inc (CRBU) indicator readings as of 2026-10-09.
CRBU's 14-day RSI is 10.8, in oversold territory. At $0.46 it is trading 73.2% below its 200-day moving average of $1.72, and below its 50-day average of $1.41. Price sits below the lower Bollinger Band ($0.61 to $1.68). ADX reads 43.8, indicating a trending market.
Overview
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
Finance Bot
Ask your questions
Start by typing a question below.
